Article Text
DTB select
MHRA issues two updates on fluoroquinolone safety
Abstract
Overview of: Medicines and Healthcare products Regulatory Agency. Fluoroquinolone antibiotics: reminder of the risk of disabling and potentially long-lasting or irreversible side effects. Drug Safety Update 2023;17:1. Medicines and Healthcare products Regulatory Agency. Fluoroquinolone antibiotics: suicidal thoughts and behaviour. Drug Safety Update 2023;17:2.
- Drug-Related Side Effects and Adverse Reactions
- Health Care Quality, Access, and Evaluation